Tandem Diabetes Care Inc. (TNDM) Plunges 5.31% on February 22

Equities Staff  |

Tandem Diabetes Care Inc. (TNDM) had a rough trading day for Monday February 22 as shares tumbled 5.31%, or a loss of $-5.21 per share, to close at $92.89. After opening the day at $97.00, shares of Tandem Diabetes Care Inc. traded as high as $97.46 and as low as $92.70. Volume was 887,592 shares over 10,794 trades, against an average daily volume of n/a shares and a total float of 62.19 million.

As a result of the decline, Tandem Diabetes Care Inc. now has a market cap of $5.78 billion. In the last year, shares of Tandem Diabetes Care Inc. have traded between a range of $123.74 and $43.69, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.

For a complete fundamental analysis of Tandem Diabetes Care Inc., check out Equities.com’s Stock Valuation Analysis report for TNDM.

Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start

Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States.

Tandem Diabetes Care Inc. is based out of San Diego, CA and has some 1,043 employees. Its CEO is John F. Sheridan.

Tandem Diabetes Care Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Tandem Diabetes Care Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: TNDM’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change